As we know, blockade of the renin-angiotensin II (Ang II) system by AT1 blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) retards the progression of CKD by reducing proteinuria [42]. This evidence concerns the gene REN and chronic kidney disease.